More about
Early Parkinson’S Disease
News
March 30, 2023
1 min read
Save
Topline results announced from phase 2 trial of treatment for early Parkinson’s disease
Neuraly has announced that its investigational NLY01 did not meet the primary study endpoint of improvement in motor symptoms in patients with early, untreated Parkinson’s disease.